Childhood Epilepsy Therapeutics - Pipeline Assessment and Market Forecasts to 2019 On 27thNovember 2014
Summary The industry analysis specialist, has released its new report, “Childhood Epilepsy Therapeutics Pipeline Assessment and Market Forecasts to 2019”. The report is an essential source of information and analysis on the global Childhood Epilepsy Therapeutics market. The report identifies the key trends shaping and driving the global Childhood Epilepsy Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Childhood Epilepsy Therapeutics sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
You can buy this Report @ http://www.jsbmarketresearch.com/healthcaremedical/r-childhood-epilepsy-therapeutics-pipeline-assessment-and-marketforecasts-135225 Scope The report provides information on the key drivers and challenges of the Childhood Epilepsy Therapeutics market. Its scope includes Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
- Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Childhood Epilepsy Therapeutics market revenues data from 2006 to 2011, forecast for eight years to 2019. - Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes. - Analysis of the current and future competition in the seven key countries Childhood Epilepsy Therapeutics market. - Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications. - Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Childhood Epilepsy Therapeutics market. - Analysis of key recent licensing and partnership agreements in Childhood Epilepsy Therapeutics market
Reasons to buy The report will enhance your decision making capability. It will allow you to - Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline. - Develop business strategies by understanding the trends shaping and driving the global Childhood Epilepsy Therapeutics market. - Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Childhood Epilepsy Therapeutics market in future. - Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors. - Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage. - Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships. Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
- What’s the next big thing in the global Childhood Epilepsy Therapeutics market landscape? – Identify, understand and capitalize.
Other industries we cover: • • • • • • • • •
Advertising and Media Automotive and Parts Consumer Goods Healthcare and Medical Finance and Banking Food and Beverages Travel and Tourism Textiles and Clothing SWOT Analysis
Discounts on Market Research Reports till 31st December, 2014 For more inquiries, contact at +91 - 998 729 5242 / contact@jsbmarketresearch.com Table of Content 2 Childhood Epilepsy Therapeutics - Introduction 2.1 Overview 2.1.1 Types of Epilepsy 2.1.2 Childhood Epilepsy Syndromes 2.2 Etiology and Pathophysiology 2.3 Epidemiology 2.3.1 The US 2.3.2 EU 2.3.3 Japan 2.3.4 Health Related Quality of Life (HRQoL) 2.4 Symptoms 2.5 Diagnosis 2.5.1 Tests 2.6 Treatment and Management Pattern 2.6.1 Pharmacological Treatment Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
2.6.2 Ketogenic Diet 2.6.3 Epilepsy Surgery 2.7 Referral Pathway 2.8 GlobalData Pipeline Report Guidance 3 Childhood Epilepsy Therapeutics - Market Characterization 3.1 Overview 3.2 Childhood Epilepsy Therapeutics Market Size (2006-2011) - Global 3.3 Childhood Epilepsy Therapeutics Market Forecast (2011 - 2019) - Global 3.4 Childhood Epilepsy Therapeutics Market Size (2006 - 2011) - The US 3.5 Childhood Epilepsy Therapeutics Market Forecast (2011 - 2019) - The US 3.6 Childhood Epilepsy Therapeutics Market Size (2006 - 2011) - France 3.7 Childhood Epilepsy Therapeutics Market Forecast (2011 - 2019) - France 3.8 Childhood Epilepsy Therapeutics Market Size (2006 - 2011) - Germany 3.9 Childhood Epilepsy Therapeutics Market Forecast (2011-2019) - Germany 3.10 Childhood Epilepsy Therapeutics Market Size (2006-2011) - Italy 3.11 Childhood Epilepsy Therapeutics Market Forecast (2011 - 2019) - Italy 3.12 Childhood Epilepsy Therapeutics Market Size (2006 - 2011) - Spain 3.13 Childhood Epilepsy Therapeutics Market Forecast (2011 - 2019) - Spain 3.14 Childhood Epilepsy Therapeutics Market Size (2006-2011) - The UK 3.15 Childhood Epilepsy Therapeutics Market Forecast (2011 - 2019) - The UK 3.16 Childhood Epilepsy Therapeutics Market Size (2006-2011) - Japan 3.17 Childhood Epilepsy Therapeutics Market Forecast (2011 - 2019) - Japan 3.18 Drivers and Barriers 3.18.1 Drivers for Childhood Epilepsy Therapeutics Market 3.18.2 Barriers for the Childhood Epilepsy Therapeutics Market 3.19 Opportunity and Unmet Needs 3.20 Key Takeaway 4 Childhood Epilepsy Therapeutics Market - Competitive Assessment 4.1 Overview 4.2 Strategic Competitor Assessment 4.3 Product Profile for the Major Marketed Products in the Childhood Epilepsy Disorders Therapeutics market 4.3.1 Lamictal (lamotrigine) 4.3.2 Topamax (topiramate) 4.3.3 Sabril (vigabatrin) 4.3.4 Keppra (levetiracetam) 4.3.5 Trileptal (oxcarbazepine) 4.3.6 Key Takeaway 5 Childhood Epilepsy Therapeutics - Pipeline Assessment Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
5.1 Overview 5.2 Strategic Pipeline Assessment 5.3 Pipeline by Phases of Development 5.3.1 Childhood Epilepsy Therapeutics - Filed Pipeline 5.3.2 Childhood Epilepsy Therapeutics - Phase III Pipeline 5.3.3 Childhood Epilepsy Therapeutics - Phase II/III Pipeline 5.3.4 Childhood Epilepsy Therapeutics - Phase II Pipeline 5.3.5 Childhood Epilepsy Therapeutics-Phase I Pipeline 5.4 Childhood Epilepsy Therapeutics Market - Clinical Pipeline by Mechanism of Action 5.5 Technology Trends Analytic Framework 5.6 Promising Drugs under Clinical Development 5.7 Profile for Promising Drugs 5.7.1 SPN-538 5.7.2 Brivaracetam 5.8 Key Takeaway 6 Childhood Epilepsy Therapeutics:Clinical Trials Mapping 6.1 Overview 6.2 Clinical Trials by Region/Country (The US, EU5 and Japan) 6.3 Clinical Trials by Phase 6.4 Clinical Trials by Trial Status 6.5 Prominent Sponsors 6.6 Top Companies Participating in Therapeutics Clinical Trials 7 Childhood Epilepsy Therapeutics:Strategic Assessment 7.1 Key Events Impacting the Future Market 7.2 Future Market Competition Scenario 8 Childhood Epilepsy Therapeutics - Future Players 8.1 Introduction 8.2 Company Profiles 8.2.1 UCB S.A. 8.2.2 Supernus Pharmaceuticals 8.2.3 Eisai Co., Ltd. 8.2.4 Kirin Holdings Company, Limited 8.2.5 GlaxoSmithKline plc 8.2.6 Pfizer 8.2.7 Bial Portela C.S.A. 9 Appendix 9.1 Market Definitions 9.2 Abbreviations 9.3 Research Methodology Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
9.3.1 Coverage 9.3.2 Secondary Research 9.3.3 Forecasting 9.3.4 Primary Research 9.3.5 Expert Panel Validation 9.4 Contact Us 9.5 Disclaimer 9.6 Bibliography
List Of Tables Table 1: AED options by Seizure Types Table 2: AED Options by Childhood Epilepsy Syndromes Table 3: Childhood Epilepsy Therapeutics Market, Global, Revenue($m), 2006-2011 Table 4: Childhood Epilepsy Therapeutics Market, Global, Forecast, ($m), 2011 - 2019 Table 5: Childhood Epilepsy Therapeutics Market, The US, Revenue ($m), 2006 - 2011 Table 6: Childhood Epilepsy Therapeutics Market, The US, Forecast ($m), 2011 - 2019 Table 7: Childhood Epilepsy Therapeutics Market, France, Revenue($m), 2006 - 2011 Table 8: Childhood Epilepsy Therapeutics Market, France, Forecast ($m), 2011 - 2019 Table 9: Childhood Epilepsy Therapeutics Market, Germany, Revenue ($m), 2006 - 2011 Table 10: Childhood Epilepsy Therapeutics Market, Germany, Forecast ($m), 2011 - 2019 Table 11: Childhood Epilepsy Therapeutics Market, Italy, Revenue ($m), 2006 - 2011 Table 12: Childhood Epilepsy Therapeutics Market, Italy, Forecast ($m), 2011 - 2019 Table 13: Childhood Epilepsy Therapeutics Market, Spain, Revenue ($m), 2006 - 2011 Table 14: Childhood Epilepsy Therapeutics Market, Spain, Forecast ($m), 2011-2019 Table 15: Childhood Epilepsy Therapeutics Market, The UK, Revenue ($m), 2006-2011 Table 16: Childhood Epilepsy Therapeutics Market, The UK, Forecast ($m), 2011-2019 Table 17: Childhood Epilepsy Therapeutics Market, Japan, Revenue ($m), 2006-2011 Table 18: Childhood Epilepsy Therapeutics Market, Japan, Forecast ($m), 2011-2019 Table 19: Efficacy Results in Double-Blind, Placebo-Controlled, Add-On Epilepsy Trials Table 20: Spasm Freedom by Primary Criteria Table 21: Reduction in Mean Over Placebo in Weekly Frequency of Partial Onset Seizures Table 22: Summary of Percentage Change in Partial Seizure Frequency from Baseline for Placebo-Controlled Adjunctive Therapy Trials Table 23: Childhood Epilepsy Therapeutics, Regulatory Filed Pipeline, 2011 Table 24: Childhood Epilepsy Therapeutics, Phase III Pipeline, 2011 Table 25: Childhood Epilepsy Therapeutics, Phase II/III Pipeline, 2011 Table 26: Childhood Epilepsy Therapeutics, Phase II Pipeline, 2011 Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Table 27: Childhood Epilepsy Therapeutics, Phase I Pipeline, 2011 Table 28: Childhood Epilepsy Therapeutics - Most Promising Drugs Under Clinical Development, 2011 Table 29: Childhood Epilepsy Therapeutics Market, Number of Clinical Trials by Region, 2011 Table 30: Childhood Epilepsy Therapeutics Market, Number of Clinical Trials by Phase of Development, 2011 Table 31: Childhood Epilepsy Therapeutics Market, Global, Number of Clinical Trials by Trial Status, 2011 Table 32: Childhood Epilepsy Therapeutics Market, Global, Number of Clinical Trials by Prominent Sponsors, 2011 Table 33: Childhood Epilepsy Therapeutics Market, Global, Clinical Trials by Top Companies, 2011 Table 34: UCB, CNS Pipeline, 2011 Table 35: UCB, Epilepsy Pipeline, 2011 Table 36: Supernus Pharmaceuticals, Inc., CNS Pipeline, 2011 Table 37: Supernus Pharmaceuticals, Inc., Epilepsy Pipeline, 2011 Table 38: Eisai Co., Ltd., CNS Pipeline, 2011 Table 39: Eisai Co., Ltd., Epilepsy Pipeline, 2011 Table 40: Kyowa Hakko Kirin Co., Ltd, CNS Pipeline, 2011 Table 41: Kyowa Hakko Kirin Co., Ltd, Epilepsy Pipeline, 2011 Table 42: GSK, CNS Pipeline, 2011 Table 43: GSK, Epilepsy Pipeline, 2011 Table 44: Pfizer, CNS Pipeline, 2011 Table 45: Pfizer, Childhood Epilepsy Pipeline, 2011 Table 46: Bial-Portela C S.A., CNS Pipeline, 2011 Table 47: Bial-Portela C S.A., Pipeline for Childhood Epilepsy, 2011
List Of Figures Figure 1: Referral Pathway for Childhood Epilepsy Disorders Figure 2: Childhood Epilepsy Therapeutics Market, Global, Revenue ($m), 2006 - 2011 Figure 3: Childhood Epilepsy Therapeutics Market, Global, Forecast ($m), 2011-2019 Figure 4: Childhood Epilepsy Therapeutics Market, The US, Revenue ($m), 2006-2011 Figure 5: Childhood Epilepsy Therapeutics Market, The US, Forecast ($m), 2011 - 2019 Figure 6: Childhood Epilepsy Therapeutics Market, France, Revenue($m), 2006 - 2011 Figure 7: Childhood Epilepsy Therapeutics Market, France, Forecast ($m), 2011 - 2019 Figure 8: Childhood Epilepsy Therapeutics Market, Germany, Revenue ($m), 2006 - 2011 Figure 9: Childhood Epilepsy Therapeutics Market, Germany, Forecast ($m), 2011 - 2019 Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Figure 10: Childhood Epilepsy Therapeutics Market, Italy, Revenue ($m), 2006 - 2011 Figure 11: Childhood Epilepsy Therapeutics Market, Italy, Forecast ($m), 2011 - 2019 Figure 12: Childhood Epilepsy Therapeutics Market, Spain, Revenue ($m), 2006 - 2011 Figure 13: Childhood Epilepsy Therapeutics Market, Spain, Forecast ($m), 2011-2019 Figure 14: Childhood Epilepsy Therapeutics Market, The UK, Revenue ($m), 2006-2011 Figure 15: Childhood Epilepsy Therapeutics Market, The UK, Forecast ($m), 2011-2019 Figure 16: Childhood Epilepsy Therapeutics Market, Japan, Revenue ($m), 2006-2011 Figure 17: Childhood Epilepsy Therapeutics Market, Japan, Forecast ($m), 2011-2019 Figure 18: Opportunity and Unmet Need in the Childhood Epilepsy Therapeutics Market, 2011 Figure 19: Strategic Competitor Assessment of the Major Marketed Products in Childhood Epilepsy, 2011 Figure 20: Childhood Epilepsy Therapeutics Pipeline by Phase of Clinical Development (%), 2011 Figure 21: Childhood Epilepsy Therapeutics, Clinical Pipeline by Mechanism of Action (%), 2011 Figure 22: Technology Trends Analytic Framework of the Childhood Epilepsy Therapeutics Pipeline, 2011 Figure 23: Technology Trends Analytic Framework of the Childhood Epilepsy Therapeutics Pipeline - Description, 2011 Figure 24: Childhood Epilepsy Therapeutics Market, Number of Clinical Trials by Region, 2011 Figure 25: Childhood Epilepsy Therapeutics Market, Global, Clinical Trials by Phase of Development (%), 2011 Figure 26: Childhood Epilepsy Therapeutics Market, Global, Clinical Trials by Trial Status (%), 2011 Figure 27: Childhood Epilepsy Therapeutics Market, Global, Clinical Trials by Overall Sponsors (%), 2011 Figure 28: Childhood Epilepsy Therapeutics Market, Global, Clinical Trials by Prominent Sponsors (%), 2011 Figure 29: Childhood Epilepsy Therapeutics Market, Global, Number of Clinical Trials by Top Companies, 2011 Figure 30: Key Events Competition in the Childhood Epilepsy Therapeutics, 2011 Figure 31: Implications for Future Market Competition in the Childhood Epilepsy, 2011 Figure 32: Childhood Epilepsy Therapeutics Market, Clinical Pipeline by Company, 2011 Figure 33: GlobalData Market Forecasting Model
Report Price: Licence Type
Price
$ 3995
Site Licence
$ 7990
Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Enterprise Wide Licence
$ 11985
Related Reports: Vitiligo Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Chronic Urticaria or Hives Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Peptic Ulcer Therapeutics- Pipeline Assessment and Market Forecasts to 2018 Hunter Syndrome Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Narcolepsy Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Myelofibrosis Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Phenylketonuria Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Urinary Tract Infections (UTI) Therapeutics - Pipeline Assessment and Market Forecasts to 2018 Interstitial Cystitis Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Acute Respiratory Distress Syndrome (ARDS) Therapeutics - Pipeline Assessment and Market Forecasts to 2019
You can order this report by calling on +91 - 998 7295 242 or mail us your contact details at contact@jsbmarketresearch.com About JSB Market Research:JSB market research is a leading player in the market of research report distribution. It is onestop-shop for all information related to market research for any sector of the industry. Along with providing in-depth analysis though reports, JSB market research also provides regular updates of the market though newsletters. Our reports are a well-researched work of market researchers with an extensive knowledge and a good level of market experience.
To know more on Childhood Epilepsy Therapeutics - Pipeline Assessment and Market Forecasts to 2019 http://www.jsbmarketresearch.com/healthcare-medical/r-childhood-epilepsytherapeutics-pipeline-assessment-and-market-forecasts-135225 Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/